Pricing Log in Create free account
Reset Show values
Sector
Industry
Country
Exclude ADRs
Ticker
Market Cap

Your own ranges are part of Powerpack. Powerpack

Stock Price

Your own ranges are part of Powerpack. Powerpack

Beta

Your own ranges are part of Powerpack. Powerpack

Employees

Your own ranges are part of Powerpack. Powerpack

Years since IPO

Your own ranges are part of Powerpack. Powerpack

S&P 500 Member
Nasdaq 100 Member
Dow Jones Member
Price Change (1M)

Your own ranges are part of Powerpack. Powerpack

Price Change (1Y)

Your own ranges are part of Powerpack. Powerpack

Price Change (YTD)

Your own ranges are part of Powerpack. Powerpack

52-week high (new)
Insider Ownership

Your own ranges are part of Powerpack. Powerpack

Recommendation Rating

Your own ranges are part of Powerpack. Powerpack

Target vs Price (Average)

Your own ranges are part of Powerpack. Powerpack

TTM trailing twelve months Q latest quarter A latest fiscal year D daily, from the latest close

Showing the 10 largest of 621 matches.
1 filter active
median
thirds
Free account

See all 621 matches

This screen shows only its 10 largest companies. A free account shows every match of every screen you run, and keeps one screen for you. No card.

Create free account
Powerpack

Export it, tune it, and hear when it changes

Download any screen to Excel, set your own range on any filter, and get an email the day a company enters or leaves a screen you saved.

Start 7-day free trial

Try Powerpack free for 7 days, then $99 / year ($8.25 a month). Cancel any time.

Also in Powerpack: every quarter, analyst estimates, API & MCP access. Compare plans

Table Snapshots
No.
1 VRTX Vertex Pharmaceuticals Incorporated Revenue Growth for VRTX EPS Growth (diluted) for VRTX Net Income Growth for VRTX Operating Income Growth for VRTX Free Cash Flow Growth for VRTX 3Y Reveue Growth (CAGR) for VRTX 5Y Revenue Growth (CAGR) for VRTX 10Y Revenue Growth (CAGR) for VRTX 5Y Net Income Growth (CAGR) for VRTX 10.59% 9.40%
2 MRNA Moderna, Inc. Revenue Growth for MRNA EPS Growth (diluted) for MRNA Net Income Growth for MRNA Operating Income Growth for MRNA Free Cash Flow Growth for MRNA 3Y Reveue Growth (CAGR) for MRNA 5Y Revenue Growth (CAGR) for MRNA 10Y Revenue Growth (CAGR) for MRNA 5Y Net Income Growth (CAGR) for MRNA 43.52% 26.78%
3 REGN Regeneron Pharmaceuticals, Inc. Revenue Growth for REGN EPS Growth (diluted) for REGN Net Income Growth for REGN Operating Income Growth for REGN Free Cash Flow Growth for REGN 3Y Reveue Growth (CAGR) for REGN 5Y Revenue Growth (CAGR) for REGN 10Y Revenue Growth (CAGR) for REGN 5Y Net Income Growth (CAGR) for REGN 4.10% 20.71%
4 ARGX argenex SE Revenue Growth for ARGX EPS Growth (diluted) for ARGX Net Income Growth for ARGX Operating Income Growth for ARGX Free Cash Flow Growth for ARGX 3Y Reveue Growth (CAGR) for ARGX 5Y Revenue Growth (CAGR) for ARGX 10Y Revenue Growth (CAGR) for ARGX 5Y Net Income Growth (CAGR) for ARGX 30.72% 33.82%
5 ONC BeOne Medicines Ltd. - Sponsored ADR Revenue Growth for ONC EPS Growth (diluted) for ONC Net Income Growth for ONC Operating Income Growth for ONC Free Cash Flow Growth for ONC 3Y Reveue Growth (CAGR) for ONC 5Y Revenue Growth (CAGR) for ONC 10Y Revenue Growth (CAGR) for ONC 5Y Net Income Growth (CAGR) for ONC 29.90% 73.22%
6 RPRX Royalty Pharma PLC Revenue Growth for RPRX EPS Growth (diluted) for RPRX Net Income Growth for RPRX Operating Income Growth for RPRX Free Cash Flow Growth for RPRX 3Y Reveue Growth (CAGR) for RPRX 5Y Revenue Growth (CAGR) for RPRX 10Y Revenue Growth (CAGR) for RPRX 5Y Net Income Growth (CAGR) for RPRX 9.61% 10.92%
7 RVMD Revolution Medicines, Inc. Revenue Growth for RVMD EPS Growth (diluted) for RVMD Net Income Growth for RVMD Operating Income Growth for RVMD Free Cash Flow Growth for RVMD 3Y Reveue Growth (CAGR) for RVMD 5Y Revenue Growth (CAGR) for RVMD 10Y Revenue Growth (CAGR) for RVMD 5Y Net Income Growth (CAGR) for RVMD 56.68% 63.75%
8 GMAB Genmab A/S Sponsored ADR Revenue Growth for GMAB EPS Growth (diluted) for GMAB Net Income Growth for GMAB Operating Income Growth for GMAB Free Cash Flow Growth for GMAB 3Y Reveue Growth (CAGR) for GMAB 5Y Revenue Growth (CAGR) for GMAB 10Y Revenue Growth (CAGR) for GMAB 5Y Net Income Growth (CAGR) for GMAB 45.64% 22.10%
9 ROIV Roivant Sciences Ltd. Revenue Growth for ROIV EPS Growth (diluted) for ROIV Net Income Growth for ROIV Operating Income Growth for ROIV Free Cash Flow Growth for ROIV 3Y Reveue Growth (CAGR) for ROIV 5Y Revenue Growth (CAGR) for ROIV 10Y Revenue Growth (CAGR) for ROIV 5Y Net Income Growth (CAGR) for ROIV 5.26% 9.28%
10 INCY Incyte Corporation Revenue Growth for INCY EPS Growth (diluted) for INCY Net Income Growth for INCY Operating Income Growth for INCY Free Cash Flow Growth for INCY 3Y Reveue Growth (CAGR) for INCY 5Y Revenue Growth (CAGR) for INCY 10Y Revenue Growth (CAGR) for INCY 5Y Net Income Growth (CAGR) for INCY 154.08% 10.47%